Skip to content

Clinical trials

Recruiting Pulmonary Fibrosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Status: Recruiting Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20101
20141
20182
20212
20221
20242
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic2
Peter Caravan2
Cedars-Sinai Medical Center1
Duke University1
InSilico Medicine Hong Kong Limited1
Massachusetts General Hospital1
National Heart, Lung, and Blood Institute (NHLBI)1
National Human Genome Research Institute (NHGRI)1
National Institute of Environmental Health Sciences (NIEHS)1
Northwestern University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis22
Idiopathic Pulmonary Fibrosis9
Lung Diseases, Interstitial9
Lung Diseases4
Fibrosis2
Albinism1
Alveolitis, Extrinsic Allergic1
Asthma1
Bone Marrow Failure Disorders1
Chronic Cough1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.